Cargando…

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey

Road safety is an important concern amidst expanding worldwide access to legal cannabis. The present study reports on the driving-related subsection of the Cannabis as Medicine Survey 2020 (CAMS-20) which surveyed driving-related behaviors, attitudes, and perceptions among Australian medical cannabi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arkell, Thomas R., Abelev, Sarah V., Mills, Llewellyn, Suraev, Anastasia, Arnold, Jonathon C., Lintzeris, Nicholas, McGregor, Iain S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481606/ https://www.ncbi.nlm.nih.gov/pubmed/37674243 http://dx.doi.org/10.1186/s42238-023-00202-y

Ejemplares similares

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)
por: Lintzeris, Nicholas, et al.
Publicado: (2022)

Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
por: Suraev, Anastasia, et al.
Publicado: (2023)

Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
por: Lintzeris, Nicholas, et al.
Publicado: (2020)

Knowledge and attitudes of Australian general practitioners towards medicinal cannabis: a cross-sectional survey
por: Karanges, Emily A, et al.
Publicado: (2018)

Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients
por: Benson, Melissa J, et al.
Publicado: (2020)

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

The “Next Day” Effects of Cannabis Use: A Systematic Review
por: McCartney, Danielle, et al.
Publicado: (2023)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease
por: Benson, Melissa J, et al.
Publicado: (2020)

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
por: Arkell, Thomas R., et al.
Publicado: (2021)

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
por: Arnold, Jonathon C., et al.
Publicado: (2022)

Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020)

Detection of Δ(9) THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices
por: Arkell, Thomas R., et al.
Publicado: (2019)

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
por: Mills, Llewellyn, et al.
Publicado: (2022)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021–2022 survey
por: Bawa, Zeeta, et al.
Publicado: (2022)

A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis
por: Bawa, Zeeta, et al.
Publicado: (2022)

Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
por: McCartney, Danielle, et al.
Publicado: (2022)

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
por: Cairns, Elizabeth A., et al.
Publicado: (2023)

Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ(9)-THC at Human CB(1) and CB(2) Receptors
por: Santiago, Marina, et al.
Publicado: (2019)

Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
por: Heblinski, Marika, et al.
Publicado: (2020)

A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel function
por: Milligan, Carol J., et al.
Publicado: (2022)

Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
por: McCartney, Danielle, et al.
Publicado: (2020)

Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2022)

Aggressive Driving Behaviours in Cannabis Users. The Influence of Consumer Characteristics
por: Ortiz-Peregrina, Sonia, et al.
Publicado: (2021)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Cannabis use, attitudes, regulation and health: Survey data from an urban population of users and non-users
por: Znoj, Hansjörg, et al.
Publicado: (2021)

Orally administered cannabidiol does not produce false‐positive tests for Δ(9)‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000
por: McCartney, Danielle, et al.
Publicado: (2021)

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
por: Bhardwaj, Anjali K., et al.
Publicado: (2018)

Cannabis and Driving
por: Pearlson, Godfrey D., et al.
Publicado: (2021)

Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Clinical Trial
por: Marcotte, Thomas D., et al.
Publicado: (2022)

Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
por: Suraev, Anastasia, et al.
Publicado: (2020)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Statistics on Cannabis Users Skew Perceptions of Cannabis Use
por: Burns, Rachel M., et al.
Publicado: (2013)

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)
por: Mersiades, Antony J, et al.
Publicado: (2018)

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy
por: Anderson, Lyndsey L., et al.
Publicado: (2021)

Adolescent Oxytocin Exposure Causes Persistent Reductions in Anxiety and Alcohol Consumption and Enhances Sociability in Rats
por: Bowen, Michael T., et al.
Publicado: (2011)

Assessment of Medical Cannabis and Health-Related Quality of Life
por: Arkell, Thomas R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ec71s4hiak0m9kaumd01arejat